Look for:

Our offer for

BAUSCH HEALTH COMPANIES INC.


ISIN:
CA0717341071
WKN:
071734107

2024/05/29 08:04:26
Price
5.774 EUR
Difference -0.74% (-0.04)

General attributes

ISINCA0717341071
SymbolBHC
ExchangeMunich
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)2,096 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)5.632 EUR (1,500)
Ask (Ask size)5.672 EUR (1,500)
Open5.774 EUR
High5.774 EUR
Low5.774 EUR
Close (prev. day)5.817 EUR
VWAP7.53 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BAUSCH HEALTH COMPANIES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/05/29 en Global Equity Ratings PDF Download
2024/04/26 en Global Equity Ratings PDF Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download


2024/05/29 08:04:26
Price
5.774 EUR
Difference -0.74% (-0.04)

General attributes

ISINCA0717341071
SymbolBHC
ExchangeMunich
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)2,096 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)5.632 EUR (1,500)
Ask (Ask size)5.672 EUR (1,500)
Open5.774 EUR
High5.774 EUR
Low5.774 EUR
Close (prev. day)5.817 EUR
VWAP7.53 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-8.13%-25.80%-77.71%
Perf (abs.)-0.52-2.02-20.28
Beta1.371.071.75
Volatility33.2032.7259.50
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)5.950 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)7.146 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)7.864 EUR (3)
Ø price 250 days | Ø volume 250 days (pcs.)7.516 EUR (1)
YTD High | date9.800 EUR (2024/04/02)
YTD Low | date5.817 EUR (2024/05/28)
52 Weeks High | date9.800 EUR (2024/04/02)
52 Weeks Low | date5.817 EUR (2024/05/28)

All listings for BAUSCH HEALTH COMPANIES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/05/2915:335.70 EUR0.001
Toronto Stock Exchange2024/05/2916:468.38 CAD0.53337
Stuttgart2024/05/2910:055.622 EUR0.002
SIX Swiss Exchange2019/06/2817:3524.11 CHF0.001
NYSE2024/05/2916:476.115 USD3.223,336
Munich2024/05/2908:045.774 EUR0.001
Frankfurt2024/05/2908:345.615 EUR0.001
Duesseldorf2024/05/2908:105.609 EUR0.001
Berlin2024/05/2908:045.615 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=98103&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAUSCH HEALTH COS. INC.
- -
2150 St. Elzéar Boulevard West - H7L 4A8 Laval
Telefon: +1-514-744-6792
Fax: +
E-mail: -

PDF Downloads

Company report: BAUSCH HEALTH COMPANIES INC.PDF Download

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Members of Management Board

Thomas AppioChairman of Managing Board
Tage RamakrishnaMember of Executive Committee
Cees HeimanMember of Executive Committee
Fernando ZarateMember of Executive Committee
Graham JacksonMember of Executive Committee
Jeff HartnessMember of Executive Committee
Kathleen FitzpatrickMember of Executive Committee
Mirza DautbegovicMember of Executive Committee
Seana CarsonMember of Executive Committee
Tom VadakethMember of Executive Committee

Board of directors

John PaulsonChairman of Supervisory Board
Amy WechslerMember of Supervisory Board
Richard MulliganMember of Supervisory Board
Brett IcahnMember of Supervisory Board
Christian GarciaMember of Supervisory Board
Frank LeeMember of Supervisory Board
Robert PowerMember of Supervisory Board
Sarah KavanaghMember of Supervisory Board
Steven MillerMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer